GoodRx Holdings (GDRX) Long-Term Deferred Tax (2019 - 2026)

GoodRx Holdings (GDRX) has 7 years of Long-Term Deferred Tax data on file, last reported at $53.0 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 31.28% year-over-year to $53.0 million; the trailing twelve-month figure through Mar 2026 stood at $53.0 million (down 31.28% YoY), and the FY2025 full-year result was $57.1 million, down 26.0% from the prior year.
• Long-Term Deferred Tax fell to $53.0 million in Q1 2026, from $57.1 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $77.2 million in Q4 2024 to a low of $53.0 million in Q1 2026.
• A 4-year average of $66.1 million and a median of $65.3 million in 2023 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax gained 18.25% in 2024 and plunged 31.28% in 2026, its largest moves.
• Tracing GDRX's Long-Term Deferred Tax over 4 years: stood at $65.3 million in 2023, then grew by 18.25% to $77.2 million in 2024, then declined by 26.0% to $57.1 million in 2025, then dropped by 7.12% to $53.0 million in 2026.
• Business Quant data shows GDRX's Long-Term Deferred Tax at $53.0 million in Q1 2026, $57.1 million in Q4 2025, and $69.1 million in Q3 2025.